503 filings
Page 7 of 26
6-K
7pcwpuyk4lmnqe0vx
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
154a81mwrxmp 7u2
20 Nov 23
Current report (foreign)
4:55pm
6-K
ome3 ovlg
20 Nov 23
Current report (foreign)
10:06am
6-K
rru slq3m
16 Nov 23
Current report (foreign)
10:22am
6-K
9ky bc9l38t
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
phb9i3
16 Nov 23
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
9:03am
6-K
r4ycjwncypgo8x2
16 Nov 23
Third Quarter Interim Statement JANUARY – SEPTEMBER 2023
6:00am
6-K
itlg61ikhthq4qbqsec
14 Nov 23
Current report (foreign)
10:28am
6-K
4ishirmted0b1hjle30
13 Nov 23
Current report (foreign)
10:07am
6-K
a7utcoxvkxz zh
13 Nov 23
Current report (foreign)
6:25am
6-K
zy9jr178ckn60lz7
9 Nov 23
Current report (foreign)
10:32am
6-K
cu98wj1e ij0a
7 Nov 23
Current report (foreign)
10:05am
6-K
xj89a
2 Nov 23
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
9:20am
6-K
sj49pvw6
27 Oct 23
Current report (foreign)
10:26am
6-K
23kj389 emb5fp4aj8n1
26 Oct 23
Current report (foreign)
10:06am
6-K
y1gafh
25 Oct 23
Current report (foreign)
11:28am
6-K
wi0 gry15s04siz82p
25 Oct 23
Current report (foreign)
10:30am
6-K
k4um0l
24 Oct 23
Current report (foreign)
10:08am
6-K
be3ac4q81ktwli
23 Oct 23
Current report (foreign)
10:48am
6-K
c9y7492f tz7c
19 Oct 23
Current report (foreign)
10:19am